| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | — | +1.3% |
| Cost of Revenue | $999K | — | -15.8% |
| Gross Profit | $495K | — | +71.8% |
| R&D Expense | $30K | — | -9.1% |
| SG&A Expense | $1.0M | — | -5.5% |
| Operating Income | -$566K | — | +32.3% |
| Net Income | -$533K | — | +32.9% |
| EPS (Basic) | -$0.06 | — | +78.6% |
| EPS (Diluted) | -$0.06 | — | +78.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.6M | +9.2% | +126.2% |
| Accounts Receivable | $745K | +190.3% | -9.1% |
| Inventory | $248K | +5.1% | +13.9% |
| Current Assets | $7.5M | +22.3% | +78.7% |
| Total Assets | $7.9M | +22.3% | +73.5% |
| Current Liabilities | $1.7M | +31.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$927K | — | -636.0% |
| Investing Cash Flow | $109 | — | +0.0% |
| Financing Cash Flow | $1.4M | — | — |
| -29.0% |
| Long-term Debt | $230K | -41.7% | -32.7% |
| Total Liabilities | $2.0M | +21.0% | -29.5% |
| Stockholders' Equity | $5.9M | +22.7% | +244.8% |